Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Crossref

1. Liver Fibrosis is Associated with NAFLD Activity Score in Chronic Hepatitis B Patients with Liver Steatosis

- Li-Li Wu

- Jing Zhou

- Qing-Xian Cai

- Ya-Xin Huang

- Dong-Ying Xie

- Zhi-Liang Gao

- Hong Deng

2. Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease

- Sheng-Hao Zhu

- Kenneth I. Zheng

- Di-Shuang Hu

- Feng Gao

- Rafael S. Rios

- Gang Li

- Yang-Yang Li

- Christopher D. Byrne

- Giovanni Targher

- Yong-Ping Chen

- Ming-Hua Zheng

3. Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease—a randomized controlled trial

- Yuan-yuan Wang

- Fang Tian

- Xiao-lu Qian

- Hui-min Ying

- Zhen-feng Zhou

4. MicroRNA‐30b regulates insulin sensitivity by targeting SERCA2b in non‐alcoholic fatty liver disease

- Li‐Li Dai

- Shu‐De Li

- Yi‐Cheng Ma

- Jun‐Rui Tang

- Jun‐Yan Lv

- Yuan‐Qing Zhang

- Ying‐Lei Miao

- Yan‐Qiong Ma

- Chun‐Mei Li

- Yi‐You Chu

- Kun‐Hua Wang

- Lan‐Qing Ma

- Cheng‐Gang Zou

5. Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor

- Hui Jin Jung

- Eun Hye Nam

- Jin Young Park

- Prithwish Ghosh

- In Su Kim

6. Fecal Microbiota Transplantation for the Treatment of Nonalcoholic Fatty Liver Disease

- Lan-Feng Xue

- Wen-Hui Luo

- Li-Hao Wu

- Xing-Xiang He

- Harry Hua-Xiang Xia

- Yu Chen

7. Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI‐PDFF as the reference standard

- Rong Mu

- You Chen Xia

- Kou Yun Zhu

- Jing Yi Lu

- Qian Luo

- Lei Zhang

- Ren Kun Lin

- Xiao Bo Cai

- Ying Qu

- Lun Gen Lu

8. Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease

- Ying Zhuang Ng

- Lee Lee Lai

- Sui Weng Wong

- Siti Yatimah Mohamad

- Kee Huat Chuah

- Wah Kheong Chan

- Daisuke Tokuhara

9. Comparison of gut microbiota in male MAFLD patients with varying liver stiffness

- Yuheng Zhang

- Su Yan

- Shifeng Sheng

- Qian Qin

- Jingfeng Chen

- Weikang Li

- Tiantian Li

- Xinxin Gao

- Lin Wang

- Li Ang

- Suying Ding

10. The defining of the reference range of liver stiffness and fat attenuation parameter for healthy Chinese children

- Fansen Zeng

- Haiyan Wang

- Xufang Li

11. Prediction of posthepatectomy liver failure using transient elastography in patients with hepatitis B related hepatocellular carcinoma

- Jie-wen Lei

- Xiao-yu Ji

- Jun-feng Hong

- Wan-bin Li

- Yan Chen

- Yan Pan

- Jia Guo

12. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B

- Wei Yue

- Yan Li

- Jiawei Geng

- Ping Wang

- Li Zhang

13. A statistical analysis of the correlations among various types of clinical indexes for patients with chronic hepatitis B

- Jie Wang

- Yonglan Pu

- Yinhua Gong

- Zhonghua Li

- Xiaofang Zhu

14. Liver fibrosis is independently associated with diabetic peripheral neuropathy in type 2 diabetes mellitus

- Jinya Huang

- Rumei Li

- Naijia Liu

- Na Yi

- Hangping Zheng

- Qi Zhang

- Lianying Zhou

- Linuo Zhou

- Renming Hu

- Bin Lu

15. Mechanical microenvironment as a key cellular regulator in the liver

- Zhifeng You

- Lyu Zhou

- Wenjing Li

- Chenyu Huang

- Yanan Du

16. Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level

- Lili Wu

- Zhihui Li

- Na Gao

- Hong Deng

- Qiyi Zhao

- Zhaoxia Hu

- Junfeng Chen

- Ziying Lei

- Jinhua Zhao

- Bingliang Lin

- Zhiliang Gao

17. Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience

- Thanikan Sukaram

- Soe Thiha Maung

- Yuda Chongpison

- Tassanan Jaihan

- Chonlada Phathong

- Roongruedee Chaiteerakij

18. Effect of substrate stiffness on hepatocyte migration and cellular Young's modulus

- Tingting Xia

- Runze Zhao

- Wanqian Liu

- Qiping Huang

- Peixing Chen

- Yasinta N. Waju

- Mohanad K. Al‐ani

- Yonggang Lv

- Li Yang

19. Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies

- Xuebin Peng

- Aiping Tian

- Junfeng Li

- Yongwu Mao

- Ni Jiang

- Ting Li

- Xiaorong Mao

20. Potential Gut Microbiota Features for Non-Invasive Detection of Schistosomiasis

- Datao Lin

- Qiuyue Song

- Jiahua Liu

- Fang Chen

- Yishu Zhang

- Zhongdao Wu

- Xi Sun

- Xiaoying Wu